Patient-reported outcomes and visual acuity after 12Â months of anti-VEGF-treatment for sight-threatening diabetic macular edema in a real world setting

Our study revealed that anti-VEGF treatment improved visual acuity and central retinal thickness as well as patient-reported outcome in real world 12 months after treatment start.